Osiris sets up division for biotech devices

08/5/2009 | American City Business Journals

Osiris Therapeutics established a biosurgery unit that focuses on developing and commercializing biotech devices for orthopedic procedures. The division comprises doctors, scientists, and regulatory and manufacturing experts who developed Osteocel, a line of medical devices sold by Osiris to NuVasive for $85 million.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR
Clinical Appeals RN
MJHS
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ